Evidence map›Paper›PMID 19820068›Full record

ArticleJournal of biomolecular screening2009

Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity.

Thomas Zielinski, Adam J Kimple, Stephanie Q Hutsell, Mark D Koeff, David P Siderovski, Robert G Lowery

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biomolecular screening, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. High-resolution structure of RGS17 suggests a role for CaThe Journal of biological chemistry · 2019
    Article
  3. Article
  4. Mechanism of the intrinsic arginine finger in heterotrimeric G proteins.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Thomas ZielinskiBellBrook Labs, Madison, Wisconsin, USA.
Adam J Kimple
Stephanie Q Hutsell
Mark D Koeff
David P Siderovski
Robert G Lowery
University of North Carolina at Chapel Hill · USBellbrook Labs (United States) · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
Structural Determinants of Heterotrimeric G-protein Nucleotide CyclingR01GM082892 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SIDEROVSKI, DAVID P. · 2008 to 2011
$924k
HTS Assays for Modulators of GPCR SignalingR43NS059082 · NINDS · BELLBROOK LABS, LLC · PI LOWERY, ROBERT G · 2007 to 2007
$235k
Towards small molecule modulators of RGS proteinsF30MH074266 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIMPLE, ADAM J · 2006 to 2011
$162k
NIGMS NIH HHS R01 GM082892NIGMS NIH HHS T32 GM008719NIMH NIH HHS F30 MH074266NINDS NIH HHS R43 NS059082
6 · The paper itself

Abstract

RGS proteins are critical modulators of G-protein-coupled receptor (GPCR) signaling given their ability to deactivate Galpha subunits via GTPase-accelerating protein (GAP) activity. Their selectivity for specific GPCRs makes them attractive therapeutic targets. However, measuring GAP activity is complicated by slow guanosine diphosphate (GDP) release from Galpha and lack of solution phase assays for detecting free GDP in the presence of excess guanosine triphosphate (GTP). To overcome these hurdles, the authors developed a Galpha(i1) mutant with increased GDP dissociation and decreased GTP hydrolysis rates, enabling detection of GAP activity using steady-state GTP hydrolysis. Galpha(i1)(R178M/A326S) GTPase activity was stimulated 6- to 12-fold by RGS proteins known to act on Galpha(i) subunits and not affected by those unable to act on Galpha(i), demonstrating that the Galpha/RGS domain interaction selectivity was not altered by mutation. The selectivity and affinity of Galpha( i1)(R178M/A326S) interaction with RGS proteins was confirmed by molecular binding studies. To enable nonradioactive, homogeneous detection of RGS protein effects on Galpha(i1)(R178M/A326S), the authors developed a Transcreener fluorescence polarization immunoassay based on a monoclonal antibody that recognizes GDP with greater than 100-fold selectivity over GTP. Combining Galpha(i1)(R178M/A326S) with a homogeneous, fluorescence-based GDP detection assay provides a facile means to explore the targeting of RGS proteins as a new approach for selective modulation of GPCR signaling.

Indexed as

Biological AssayFluorescence PolarizationGTP-Binding Protein alpha Subunits, Gi-GoGuanosine DiphosphateGuanosine TriphosphateHumansHydrolysisKineticsMutant ProteinsPilot ProjectsPoint MutationProtein BindingProtein Structure, SecondaryReceptors, G-Protein-CoupledRGS ProteinsSmall Molecule LibrariesGTP-Binding Protein alpha Subunits, Gi-GoGuanosine DiphosphateGuanosine TriphosphateMutant ProteinsReceptors, G-Protein-CoupledRGS ProteinsSmall Molecule Libraries

Identifiers

PMID19820068
PMCPMC2795102
OpenAlexW2145900223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.